Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism DDX3X inhibitors(ATP-dependent RNA helicase DDX3X inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H49N5O5 |
InChIKeyXENPONAMWFKIEU-VXNXHJTFSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 11 Aug 2015 |